The global subdermal contraceptive implants market was valued at USD 1.1 billion in 2024 and is anticipated to grow at a CAGR of 3.90% from 2025 to 2034, reflecting steady but regionally uneven adoption driven by public health priorities, regulatory environments, and access disparities. Unlike short-acting methods, subdermal implants—typically single-rod devices releasing progestin over...